This is the authors' abstract. We don't add key points for this paper.
Rats immunized with bacillus Calmette-Guérin (BCG) were either treated with rifampicin plus isoniazid or received no treatment. Thoracic duct lymphocytes (TDL) obtained from these animals were tested for their ability to provide protection against Mycobacterium tuberculosis strain R1Rv in syngeneic recipients. After six months of treatment there was no difference between the two groups of donors with respect to protection conferred by their TDL. The rats receiving chemotherapy maintained their immunity despite the reduction of viable BCG to undetectably low levels in the tissues. It was concluded that effective chemotherapy for tuberculosis does not abrogate established immunity to the tubercle bacillus.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lefford et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: